OriGene Technologies, Inc.
Left ProductsProducts divider ServicesServices divider technologyTechnology divider researchResearch divider TechsupportTechSupport divider AboutAbout Right

Search Results

Your search returned 12 results.
Search:

SKU Category Vector Description Price Delivery
SC124160 Human cDNA pCMV6-XL4 MCOLN3 (untagged)-Human mucolipin 3 (MCOLN3) (10ug) NM_018298.9 $830 Immediate
RC224697 Human ORF PS100001 MCOLN3 (Myc-DDK-tagged)-Human mucolipin 3 (MCOLN3) $660 Immediate
RC224697L1 Human ORF PS100064 Lenti ORF clone of Human mucolipin 3 (MCOLN3) , Myc-DDK-tagged $1030 2-3 weeks
RC224697L2 Human ORF PS100071 Lenti ORF clone of Human mucolipin 3 (MCOLN3), mGFP tagged $1130 2-3 weeks
RC524697 Human ORF PS100001 MCOLN3 (Myc-DDK-tagged)-Human mucolipin 3 (MCOLN3), (200ug) $780 2~3 weeks
RG224697 Human ORF PS100010 MCOLN3 (GFP-tagged) - Human mucolipin 3 (MCOLN3) $730 Immediate
HP212989 Human Primer qSTAR qPCR primer pairs against Homo sapiens gene MCOLN3 NM_018298 $95 3 - 5 Days
TF303305 Human shRNA pRFP-C-RS MCOLN3 - Human, 4 unique 29mer shRNA constructs in retroviral RFP vector $498 In Stock
TG303305 Human shRNA pGFP-V-RS MCOLN3 - Human, 4 unique 29mer shRNA constructs in retroviral GFP vector $650 2 Weeks
TR303305 Human shRNA pRS MCOLN3 - Human, 4 unique 29mer shRNA constructs in retroviral untagged vector $650 2 Weeks
LY402663 Lysate Transient overexpression lysate of mucolipin 3 (MCOLN3) $480 5 days
/ UTR pMirTarget 3`UTR clone of mucolipin 3 (MCOLN3) for miRNA target validation NM_018298.9 $495 3-4 weeks
Inc 5000 Healthcare Company Copyright © 2014 OriGene Technologies, Inc. All Rights Reserved. Legal Notices.
9620 Medical Center Dr., Suite 200, Rockville, MD 20850 • 1.888.267.4436

Reproduction of any materials from this website is strictly forbidden without permission.

All Products by: Title | Price | Category | Popularity | Best Sellers Topselling Products by: Title | Price | Category | Popularity | Favorites
Popular Categories: Popularity | Our Choices | All-Round Favorites | Title Topselling Categories: Popularity | Our Choices | All-Round Favorites | Title